Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hoffer

Showing results (461-470 of 496) with videos related to

Pageof 50
Sort By:
Neurobiology of Disease|July 12, 2019
(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged miceDaniela Lecca, Miaad Bader, David Tweedie, et al.
International Journal of Molecular Sciences|March 11, 2023
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's DiseaseTung-Tai Kuo, Yuan-Hao Chen, Vicki Wang, et al.
Journal of Neuroscience Research|January 24, 2007
Apoptotic and behavioral sequelae of mild brain trauma in miceDavid Tweedie, Anat Milman, Harold W Holloway, et al.
Cell Transplantation|August 22, 2007
An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of strokeB K Harvey, G J Chen, C J Schoen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 18, 2014
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryNigel H Greig, David Tweedie, Lital Rachmany, et al.
Scientific Reports|June 18, 2017
Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degenerationLital Rachmany, David Tweedie, Vardit Rubovitch, et al.
International Journal of Molecular Sciences|April 12, 2018
Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian RatsYu-Wen Yu, Shih-Chang Hsueh, Jing-Huei Lai, et al.
Atherosclerosis|October 25, 1996
Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patientsE J Sijbrands, R G Westendorp, M J Hoffer, et al.
ACS Pharmacology & Translational Science|April 16, 2021
<i>N</i>-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS ChallengeShih Chang Hsueh, Weiming Luo, David Tweedie, et al.
Biomedicines|October 27, 2022
Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain InjuryShih Chang Hsueh, Michael T Scerba, David Tweedie, et al.
Pageof 50

Showing results (461-470 of 496) with videos related to

Sort By:
Pageof 50
Neurobiology of Disease|July 12, 2019
(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged miceDaniela Lecca, Miaad Bader, David Tweedie, et al.
International Journal of Molecular Sciences|March 11, 2023
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's DiseaseTung-Tai Kuo, Yuan-Hao Chen, Vicki Wang, et al.
Journal of Neuroscience Research|January 24, 2007
Apoptotic and behavioral sequelae of mild brain trauma in miceDavid Tweedie, Anat Milman, Harold W Holloway, et al.
Cell Transplantation|August 22, 2007
An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of strokeB K Harvey, G J Chen, C J Schoen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 18, 2014
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryNigel H Greig, David Tweedie, Lital Rachmany, et al.
Scientific Reports|June 18, 2017
Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degenerationLital Rachmany, David Tweedie, Vardit Rubovitch, et al.
International Journal of Molecular Sciences|April 12, 2018
Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian RatsYu-Wen Yu, Shih-Chang Hsueh, Jing-Huei Lai, et al.
Atherosclerosis|October 25, 1996
Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patientsE J Sijbrands, R G Westendorp, M J Hoffer, et al.
ACS Pharmacology & Translational Science|April 16, 2021
<i>N</i>-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS ChallengeShih Chang Hsueh, Weiming Luo, David Tweedie, et al.
Biomedicines|October 27, 2022
Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain InjuryShih Chang Hsueh, Michael T Scerba, David Tweedie, et al.
Pageof 50